| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | structural constituent of postsynaptic actin cytoskeleton | 2.04e-08 | 11 | 173 | 5 | GO:0098973 | |
| GeneOntologyMolecularFunction | structural constituent of postsynapse | 7.68e-06 | 32 | 173 | 5 | GO:0099186 | |
| GeneOntologyMolecularFunction | structural constituent of synapse | 3.02e-05 | 42 | 173 | 5 | GO:0098918 | |
| GeneOntologyMolecularFunction | phosphatidylinositol phospholipase C activity | 7.01e-05 | 26 | 173 | 4 | GO:0004435 | |
| GeneOntologyMolecularFunction | phospholipase C activity | 1.09e-04 | 29 | 173 | 4 | GO:0004629 | |
| GeneOntologyMolecularFunction | bicarbonate transmembrane transporter activity | 1.62e-04 | 32 | 173 | 4 | GO:0015106 | |
| GeneOntologyMolecularFunction | chloride:bicarbonate antiporter activity | 1.71e-04 | 13 | 173 | 3 | GO:0140900 | |
| GeneOntologyMolecularFunction | bicarbonate:monoatomic anion antiporter activity | 1.71e-04 | 13 | 173 | 3 | GO:0140829 | |
| GeneOntologyMolecularFunction | exoribonuclease II activity | 2.23e-04 | 3 | 173 | 2 | GO:0008859 | |
| GeneOntologyMolecularFunction | glucuronosyltransferase activity | 2.31e-04 | 35 | 173 | 4 | GO:0015020 | |
| GeneOntologyMolecularFunction | adipokinetic hormone receptor activity | 4.43e-04 | 4 | 173 | 2 | GO:0097003 | |
| GeneOntologyMolecularFunction | anandamide 8,9 epoxidase activity | 4.43e-04 | 4 | 173 | 2 | GO:0062187 | |
| GeneOntologyMolecularFunction | anandamide 11,12 epoxidase activity | 4.43e-04 | 4 | 173 | 2 | GO:0062188 | |
| GeneOntologyMolecularFunction | steroid 21-monooxygenase activity | 4.43e-04 | 4 | 173 | 2 | GO:0004509 | |
| GeneOntologyMolecularFunction | progesterone 21-hydroxylase activity | 4.43e-04 | 4 | 173 | 2 | GO:0106309 | |
| GeneOntologyMolecularFunction | helicase activity | 4.62e-04 | 158 | 173 | 7 | GO:0004386 | |
| GeneOntologyMolecularFunction | phospholipase activity | 4.78e-04 | 114 | 173 | 6 | GO:0004620 | |
| GeneOntologyMolecularFunction | transition metal ion transmembrane transporter activity | 5.64e-04 | 44 | 173 | 4 | GO:0046915 | |
| GeneOntologyMolecularFunction | chloride transmembrane transporter activity | 7.77e-04 | 125 | 173 | 6 | GO:0015108 | |
| GeneOntologyMolecularFunction | inorganic molecular entity transmembrane transporter activity | GABRR2 ATP7B TSPOAP1 NOX5 BEST2 TRPM2 SLC26A9 SLC30A2 SLC4A3 RYR2 KCNT2 SLC12A3 SLC26A7 PKD1 SLC25A28 ATP4A | 9.37e-04 | 758 | 173 | 16 | GO:0015318 |
| GeneOntologyMolecularFunction | ATP-dependent activity | ATP7B DHX40 ACTB MCM2 ZNFX1 SMC2 FANCM ACSBG1 DDX54 HELZ2 MYO15A ATP4A SLC27A5 HELLS | 9.46e-04 | 614 | 173 | 14 | GO:0140657 |
| GeneOntologyMolecularFunction | structural constituent of cytoskeleton | 9.53e-04 | 130 | 173 | 6 | GO:0005200 | |
| GeneOntologyMolecularFunction | glycerophosphodiester phosphodiesterase activity | 1.09e-03 | 6 | 173 | 2 | GO:0008889 | |
| GeneOntologyMolecularFunction | anandamide 14,15 epoxidase activity | 1.09e-03 | 6 | 173 | 2 | GO:0062189 | |
| GeneOntologyMolecularFunction | anandamide epoxidase activity | 1.09e-03 | 6 | 173 | 2 | GO:0062186 | |
| GeneOntologyMolecularFunction | lipase activity | 1.30e-03 | 138 | 173 | 6 | GO:0016298 | |
| GeneOntologyMolecularFunction | monoatomic ion transmembrane transporter activity | GABRR2 ATP7B TSPOAP1 NOX5 BEST2 TRPM2 SLC26A9 SLC30A2 SLC4A3 RYR2 KCNT2 SLC12A3 SLC26A7 PKD1 SLC25A28 ATP4A | 1.50e-03 | 793 | 173 | 16 | GO:0015075 |
| GeneOntologyMolecularFunction | phosphoric diester hydrolase activity | 1.56e-03 | 97 | 173 | 5 | GO:0008081 | |
| GeneOntologyMolecularFunction | retinoic acid binding | 1.79e-03 | 28 | 173 | 3 | GO:0001972 | |
| GeneOntologyMolecularFunction | hydrolase activity, acting on ester bonds | ABHD17A ISG20 DCLRE1B FANCM PGAP6 GDE1 PPM1A GDPD5 DUSP26 SSH1 PTPRQ PANK4 HELZ2 PLCB3 PLCL1 PLCH1 | 1.79e-03 | 807 | 173 | 16 | GO:0016788 |
| GeneOntologyMolecularFunction | phosphoric ester hydrolase activity | 2.03e-03 | 386 | 173 | 10 | GO:0042578 | |
| GeneOntologyMolecularFunction | monoatomic anion transmembrane transporter activity | 2.05e-03 | 151 | 173 | 6 | GO:0008509 | |
| GeneOntologyMolecularFunction | UDP-glycosyltransferase activity | 2.19e-03 | 153 | 173 | 6 | GO:0008194 | |
| GeneOntologyMolecularFunction | calcium ion binding | FAT4 NOX5 PCDHGA7 TRPM2 CDH23 RYR2 FAT1 CDH24 FAT2 HMCN1 OTOF C1S PLCB3 DSG4 PLCH1 | 2.25e-03 | 749 | 173 | 15 | GO:0005509 |
| GeneOntologyMolecularFunction | hexosyltransferase activity | 2.47e-03 | 211 | 173 | 7 | GO:0016758 | |
| GeneOntologyMolecularFunction | solute:inorganic anion antiporter activity | 2.64e-03 | 32 | 173 | 3 | GO:0005452 | |
| GeneOntologyMolecularFunction | intracellularly ligand-gated monoatomic ion channel activity | 2.88e-03 | 33 | 173 | 3 | GO:0005217 | |
| GeneOntologyMolecularFunction | very long-chain fatty acid-CoA ligase activity | 3.21e-03 | 10 | 173 | 2 | GO:0031957 | |
| GeneOntologyMolecularFunction | oxalate transmembrane transporter activity | 3.21e-03 | 10 | 173 | 2 | GO:0019531 | |
| GeneOntologyMolecularFunction | virion binding | 3.21e-03 | 10 | 173 | 2 | GO:0046790 | |
| GeneOntologyBiologicalProcess | homophilic cell adhesion via plasma membrane adhesion molecules | FAT4 PCDHGA7 CDH23 IGSF11 FAT1 CDH24 FAT2 HMCN1 PKD1 DSG4 IGSF9B | 5.03e-07 | 187 | 172 | 11 | GO:0007156 |
| GeneOntologyBiologicalProcess | inorganic ion transmembrane transport | GABRR2 FLNA ATP7B ANK2 TSPOAP1 NOX5 BEST2 TRPM2 SLC26A9 RGS9 SLC30A2 SLC4A3 OPA1 RYR2 AKAP9 KCNT2 SLC12A3 SLC26A7 MTOR PKD1 PLCB3 PLCH1 SLC25A28 ATP4A | 4.09e-06 | 1017 | 172 | 24 | GO:0098660 |
| GeneOntologyBiologicalProcess | postsynaptic actin cytoskeleton organization | 5.42e-06 | 31 | 172 | 5 | GO:0098974 | |
| GeneOntologyBiologicalProcess | postsynaptic cytoskeleton organization | 1.01e-05 | 35 | 172 | 5 | GO:0099188 | |
| GeneOntologyBiologicalProcess | cell-cell adhesion via plasma-membrane adhesion molecules | FAT4 PCDHGA7 CDH23 IGSF11 FAT1 CDH24 FAT2 HMCN1 PKD1 DSG4 IGSF9B MDGA1 | 1.31e-05 | 313 | 172 | 12 | GO:0098742 |
| GeneOntologyBiologicalProcess | monoatomic ion transmembrane transport | GABRR2 FLNA ATP7B ANK2 TSPOAP1 NOX5 BEST2 TRPM2 SLC26A9 RGS9 SLC30A2 SLC4A3 OPA1 RYR2 AKAP9 KCNT2 SLC12A3 SLC26A7 MTOR PKD1 PLCB3 PLCH1 SLC25A28 ATP4A | 1.89e-05 | 1115 | 172 | 24 | GO:0034220 |
| GeneOntologyBiologicalProcess | morphogenesis of a polarized epithelium | 3.30e-05 | 73 | 172 | 6 | GO:0001738 | |
| GeneOntologyBiologicalProcess | protein localization to cell-cell junction | 4.36e-05 | 24 | 172 | 4 | GO:0150105 | |
| GeneOntologyBiologicalProcess | multi-pass transmembrane protein insertion into ER membrane | 4.61e-05 | 9 | 172 | 3 | GO:0160063 | |
| GeneOntologyBiologicalProcess | glucuronate metabolic process | 6.05e-05 | 26 | 172 | 4 | GO:0019585 | |
| GeneOntologyBiologicalProcess | uronic acid metabolic process | 6.05e-05 | 26 | 172 | 4 | GO:0006063 | |
| GeneOntologyBiologicalProcess | synapse organization | ABHD17A FLNA POTEF ACTB ACTG1 IGSF11 ADNP OPA1 SORT1 POTEE SSH1 PAFAH1B1 SYN1 SEPTIN11 IGSF9B POTEI MDGA1 | 6.23e-05 | 685 | 172 | 17 | GO:0050808 |
| GeneOntologyBiologicalProcess | cell junction organization | ABHD17A FLNA ANK2 POTEF ACTB ACTG1 IGSF11 ADNP OPA1 SORT1 POTEE CDH24 SSH1 PAFAH1B1 PKHD1 SYN1 SEPTIN11 IGSF9B POTEI MDGA1 VCL | 6.42e-05 | 974 | 172 | 21 | GO:0034330 |
| GeneOntologyBiologicalProcess | regulation of cardiac muscle cell action potential | 1.08e-04 | 30 | 172 | 4 | GO:0098901 | |
| GeneOntologyBiologicalProcess | inorganic anion transmembrane transport | 1.34e-04 | 134 | 172 | 7 | GO:0098661 | |
| GeneOntologyBiologicalProcess | monoatomic ion transport | GABRR2 FLNA ATP7B ANK2 TSPOAP1 NOX5 BEST2 TRPM2 CDH23 SLC26A9 RGS9 SLC30A2 SLC4A3 OPA1 RYR2 AKAP9 KCNT2 SLC12A3 SLC26A7 MTOR PKD1 PLCB3 PLCH1 SLC25A28 ATP4A | 1.89e-04 | 1374 | 172 | 25 | GO:0006811 |
| GeneOntologyBiologicalProcess | serotonin biosynthetic process from tryptophan | 2.06e-04 | 3 | 172 | 2 | GO:0006587 | |
| GeneOntologyBiologicalProcess | regulation of SA node cell action potential | 2.06e-04 | 3 | 172 | 2 | GO:0098907 | |
| GeneOntologyBiologicalProcess | cell-cell adhesion | FLNA FAT4 PCDHGA7 ACTB ACTG1 CDH23 IGSF11 OPA1 FAT1 CDH24 FAT2 HMCN1 MTOR PKD1 PKHD1 CERCAM DSG4 IGSF9B MDGA1 VCL PNP | 2.58e-04 | 1077 | 172 | 21 | GO:0098609 |
| GeneOntologyBiologicalProcess | bicarbonate transport | 2.76e-04 | 38 | 172 | 4 | GO:0015701 | |
| GeneOntologyBiologicalProcess | monoatomic cation homeostasis | FLNA ATP7B ANK2 TSPOAP1 TRPM2 CDH23 SLC26A9 EXT2 SLC30A2 SLC4A3 RYR2 SLC12A3 PKHD1 PLCB3 PLCH1 ATP4A | 2.84e-04 | 705 | 172 | 16 | GO:0055080 |
| GeneOntologyBiologicalProcess | sequestering of calcium ion | 3.03e-04 | 153 | 172 | 7 | GO:0051208 | |
| GeneOntologyBiologicalProcess | monoatomic anion transmembrane transport | 3.03e-04 | 153 | 172 | 7 | GO:0098656 | |
| GeneOntologyBiologicalProcess | maintenance of location in cell | 3.35e-04 | 259 | 172 | 9 | GO:0051651 | |
| GeneOntologyBiologicalProcess | monoatomic cation transmembrane transport | FLNA ATP7B ANK2 TSPOAP1 NOX5 BEST2 TRPM2 RGS9 SLC30A2 OPA1 RYR2 AKAP9 KCNT2 SLC12A3 PKD1 PLCB3 PLCH1 SLC25A28 ATP4A | 3.39e-04 | 942 | 172 | 19 | GO:0098655 |
| GeneOntologyBiologicalProcess | monoatomic ion homeostasis | FLNA ATP7B ANK2 TSPOAP1 TRPM2 CDH23 SLC26A9 EXT2 SLC30A2 SLC4A3 RYR2 SLC12A3 PKHD1 PLCB3 PLCH1 ATP4A | 3.42e-04 | 717 | 172 | 16 | GO:0050801 |
| GeneOntologyBiologicalProcess | chloride transmembrane transport | 3.55e-04 | 112 | 172 | 6 | GO:1902476 | |
| GeneOntologyBiologicalProcess | regulation of transepithelial transport | 4.10e-04 | 4 | 172 | 2 | GO:0150111 | |
| GeneOntologyBiologicalProcess | regulation of atrial cardiac muscle cell action potential | 4.10e-04 | 4 | 172 | 2 | GO:0098910 | |
| GeneOntologyBiologicalProcess | atrial cardiac muscle cell to AV node cell communication | 5.00e-04 | 19 | 172 | 3 | GO:0086066 | |
| GeneOntologyBiologicalProcess | atrial cardiac muscle cell to AV node cell signaling | 5.00e-04 | 19 | 172 | 3 | GO:0086026 | |
| GeneOntologyBiologicalProcess | atrial cardiac muscle cell action potential | 5.00e-04 | 19 | 172 | 3 | GO:0086014 | |
| GeneOntologyCellularComponent | NuA4 histone acetyltransferase complex | 6.51e-06 | 32 | 175 | 5 | GO:0035267 | |
| GeneOntologyCellularComponent | H4/H2A histone acetyltransferase complex | 6.51e-06 | 32 | 175 | 5 | GO:0043189 | |
| GeneOntologyCellularComponent | H4 histone acetyltransferase complex | 3.62e-05 | 45 | 175 | 5 | GO:1902562 | |
| GeneOntologyCellularComponent | multi-pass translocon complex | 4.67e-05 | 9 | 175 | 3 | GO:0160064 | |
| GeneOntologyCellularComponent | axon | GABRR2 FLNA TSPOAP1 POTEF CYTH2 KATNB1 ACTB CNTNAP3 ACTG1 TXNRD2 ADNP OPA1 POTEE GDPD5 SSH1 PAFAH1B1 SYN1 SEPTIN11 POTEI MDGA1 | 5.95e-05 | 891 | 175 | 20 | GO:0030424 |
| GeneOntologyCellularComponent | ER membrane insertion complex | 1.96e-04 | 14 | 175 | 3 | GO:0072379 | |
| GeneOntologyCellularComponent | actin filament | 2.33e-04 | 146 | 175 | 7 | GO:0005884 | |
| GeneOntologyCellularComponent | postsynaptic specialization of symmetric synapse | 4.14e-04 | 4 | 175 | 2 | GO:0099629 | |
| GeneOntologyCellularComponent | cell-cell junction | FLNA EPPK1 ATP7B ANK2 CYTH2 ACTB ACTG1 IGSF11 FAT1 CDH24 FAT2 HMCN1 DSG4 VCL | 4.70e-04 | 591 | 175 | 14 | GO:0005911 |
| GeneOntologyCellularComponent | apical part of cell | FAT4 ATP7B ANK2 ACTG1 CDH23 SLC26A9 FAT1 SLC12A3 OTOF SLC26A7 NPC1L1 PTPRQ PKHD1 ATP4A | 4.78e-04 | 592 | 175 | 14 | GO:0045177 |
| GeneOntologyCellularComponent | costamere | 7.90e-04 | 22 | 175 | 3 | GO:0043034 | |
| GeneOntologyCellularComponent | cochlear hair cell ribbon synapse | 1.02e-03 | 6 | 175 | 2 | GO:0098683 | |
| GeneOntologyCellularComponent | extrinsic component of plasma membrane | 1.05e-03 | 137 | 175 | 6 | GO:0019897 | |
| GeneOntologyCellularComponent | histone acetyltransferase complex | 1.17e-03 | 94 | 175 | 5 | GO:0000123 | |
| GeneOntologyCellularComponent | endoplasmic reticulum membrane | MBTPS1 CYP2D6 NOX5 UGT1A5 SLC26A9 SEC11C EXT2 POMT1 LCLAT1 RYR2 NOMO1 SORT1 UGT1A4 UGT1A3 GDPD5 OTOF NOMO2 MTOR HHAT ATG9A NOMO3 SLC27A5 | 1.21e-03 | 1293 | 175 | 22 | GO:0005789 |
| GeneOntologyCellularComponent | endoplasmic reticulum subcompartment | MBTPS1 CYP2D6 NOX5 UGT1A5 SLC26A9 SEC11C EXT2 POMT1 LCLAT1 RYR2 NOMO1 SORT1 UGT1A4 UGT1A3 GDPD5 OTOF NOMO2 MTOR HHAT ATG9A NOMO3 SLC27A5 | 1.29e-03 | 1299 | 175 | 22 | GO:0098827 |
| GeneOntologyCellularComponent | dense body | 1.42e-03 | 7 | 175 | 2 | GO:0097433 | |
| GeneOntologyCellularComponent | nuclear outer membrane-endoplasmic reticulum membrane network | MBTPS1 CYP2D6 NOX5 UGT1A5 SLC26A9 SEC11C EXT2 POMT1 LCLAT1 RYR2 NOMO1 SORT1 UGT1A4 UGT1A3 GDPD5 OTOF NOMO2 MTOR HHAT ATG9A NOMO3 SLC27A5 | 1.68e-03 | 1327 | 175 | 22 | GO:0042175 |
| GeneOntologyCellularComponent | protein acetyltransferase complex | 1.83e-03 | 104 | 175 | 5 | GO:0031248 | |
| GeneOntologyCellularComponent | acetyltransferase complex | 2.25e-03 | 109 | 175 | 5 | GO:1902493 | |
| GeneOntologyCellularComponent | clathrin-sculpted glutamate transport vesicle membrane | 2.41e-03 | 9 | 175 | 2 | GO:0060203 | |
| GeneOntologyCellularComponent | clathrin-sculpted glutamate transport vesicle | 2.41e-03 | 9 | 175 | 2 | GO:0060199 | |
| GeneOntologyCellularComponent | stereocilium | 2.69e-03 | 69 | 175 | 4 | GO:0032420 | |
| GeneOntologyCellularComponent | cluster of actin-based cell projections | 2.79e-03 | 223 | 175 | 7 | GO:0098862 | |
| HumanPheno | Gray matter heterotopia | RALGAPA1 FLNA FAT4 KATNB1 ACTB POMT1 MTOR PAFAH1B1 TRAPPC10 PLCH1 | 4.84e-06 | 129 | 66 | 10 | HP:0002282 |
| MousePheno | short outer hair cell stereocilia | 8.69e-06 | 5 | 135 | 3 | MP:0004531 | |
| MousePheno | abnormal outer hair cell stereocilia length | 8.69e-06 | 5 | 135 | 3 | MP:0014411 | |
| MousePheno | abnormal cochlear hair cell stereociliary bundle morphology | 2.76e-05 | 91 | 135 | 7 | MP:0004521 | |
| MousePheno | abnormal outer hair cell stereociliary bundle morphology | 4.86e-05 | 68 | 135 | 6 | MP:0004527 | |
| MousePheno | increased susceptibility to age-related hearing loss | 6.39e-05 | 23 | 135 | 4 | MP:0004748 | |
| MousePheno | decreased cochlear hair cell stereocilia number | 1.05e-04 | 26 | 135 | 4 | MP:0004523 | |
| Domain | Actin_CS | 2.24e-07 | 16 | 168 | 5 | IPR004001 | |
| Domain | ACTINS_2 | 3.15e-07 | 17 | 168 | 5 | PS00432 | |
| Domain | Actin/actin-like_CS | 4.32e-07 | 18 | 168 | 5 | IPR020902 | |
| Domain | ACTINS_ACT_LIKE | 5.83e-07 | 19 | 168 | 5 | PS01132 | |
| Domain | - | 2.55e-06 | 25 | 168 | 5 | 3.20.20.190 | |
| Domain | PLC-like_Pdiesterase_TIM-brl | 2.55e-06 | 25 | 168 | 5 | IPR017946 | |
| Domain | DUF2012 | 2.84e-06 | 4 | 168 | 3 | PF09430 | |
| Domain | DUF2012 | 2.84e-06 | 4 | 168 | 3 | IPR019008 | |
| Domain | Actin | 7.80e-06 | 31 | 168 | 5 | IPR004000 | |
| Domain | Actin | 7.80e-06 | 31 | 168 | 5 | PF00022 | |
| Domain | ACTIN | 7.80e-06 | 31 | 168 | 5 | SM00268 | |
| Domain | Cadherin | 1.15e-05 | 118 | 168 | 8 | IPR002126 | |
| Domain | Carb-bd-like_fold | 3.87e-05 | 8 | 168 | 3 | IPR013784 | |
| Domain | Cadherin_CS | 5.80e-05 | 109 | 168 | 7 | IPR020894 | |
| Domain | CADHERIN_1 | 7.30e-05 | 113 | 168 | 7 | PS00232 | |
| Domain | Cadherin | 7.30e-05 | 113 | 168 | 7 | PF00028 | |
| Domain | CADHERIN_2 | 7.72e-05 | 114 | 168 | 7 | PS50268 | |
| Domain | - | 7.72e-05 | 114 | 168 | 7 | 2.60.40.60 | |
| Domain | CA | 8.15e-05 | 115 | 168 | 7 | SM00112 | |
| Domain | Cadherin-like | 8.61e-05 | 116 | 168 | 7 | IPR015919 | |
| Domain | CarboxyPept_regulatory_dom | 1.91e-04 | 13 | 168 | 3 | IPR014766 | |
| Domain | - | 1.91e-04 | 13 | 168 | 3 | 2.60.40.1120 | |
| Domain | - | 2.17e-04 | 95 | 168 | 6 | 2.60.120.200 | |
| Domain | Ig-like_fold | FLNA TSPOAP1 REL IGSF11 TGM6 IL18R1 NOMO1 KIAA0319 HMCN1 NOMO2 VSTM2L WFIKKN2 PKHD1 IGSF9B MDGA1 NOMO3 ADGRA3 | 2.18e-04 | 706 | 168 | 17 | IPR013783 |
| Domain | EF-hand_like | 3.00e-04 | 15 | 168 | 3 | PF09279 | |
| Domain | PI-PLC-Y | 3.00e-04 | 15 | 168 | 3 | PF00387 | |
| Domain | PLCYc | 3.00e-04 | 15 | 168 | 3 | SM00149 | |
| Domain | PLipase_C_Pinositol-sp_Y | 3.00e-04 | 15 | 168 | 3 | IPR001711 | |
| Domain | PIPLC_Y_DOMAIN | 3.00e-04 | 15 | 168 | 3 | PS50008 | |
| Domain | PI-PLC_fam | 3.00e-04 | 15 | 168 | 3 | IPR001192 | |
| Domain | PLC_EF-hand-like | 3.00e-04 | 15 | 168 | 3 | IPR015359 | |
| Domain | - | FLNA TSPOAP1 REL IGSF11 TGM6 IL18R1 NOMO1 HMCN1 NOMO2 VSTM2L WFIKKN2 PKHD1 IGSF9B MDGA1 NOMO3 ADGRA3 | 3.28e-04 | 663 | 168 | 16 | 2.60.40.10 |
| Domain | LAM_G_DOMAIN | 3.67e-04 | 38 | 168 | 4 | PS50025 | |
| Domain | CarboxyPept-like_regulatory | 4.43e-04 | 17 | 168 | 3 | IPR008969 | |
| Domain | Laminin_G_2 | 4.48e-04 | 40 | 168 | 4 | PF02210 | |
| Domain | PI-PLC-X | 5.28e-04 | 18 | 168 | 3 | PF00388 | |
| Domain | PLCXc | 5.28e-04 | 18 | 168 | 3 | SM00148 | |
| Domain | PIPLC_X_DOMAIN | 6.23e-04 | 19 | 168 | 3 | PS50007 | |
| Domain | PLipase_C_PInositol-sp_X_dom | 6.23e-04 | 19 | 168 | 3 | IPR000909 | |
| Domain | LamG | 6.48e-04 | 44 | 168 | 4 | SM00282 | |
| Domain | ConA-like_dom | 8.41e-04 | 219 | 168 | 8 | IPR013320 | |
| Domain | UDPGT | 8.44e-04 | 21 | 168 | 3 | PF00201 | |
| Domain | UDPGT | 8.44e-04 | 21 | 168 | 3 | PS00375 | |
| Domain | UDP_glucos_trans | 8.44e-04 | 21 | 168 | 3 | IPR002213 | |
| Domain | PKD/REJ-like | 1.18e-03 | 6 | 168 | 2 | IPR002859 | |
| Domain | REJ | 1.18e-03 | 6 | 168 | 2 | PF02010 | |
| Domain | GP_PDE_dom | 1.64e-03 | 7 | 168 | 2 | IPR030395 | |
| Domain | GlyceroP-diester-Pdiesterase | 1.64e-03 | 7 | 168 | 2 | IPR004129 | |
| Domain | GDPD | 1.64e-03 | 7 | 168 | 2 | PF03009 | |
| Domain | GP_PDE | 1.64e-03 | 7 | 168 | 2 | PS51704 | |
| Domain | Laminin_G | 1.84e-03 | 58 | 168 | 4 | IPR001791 | |
| Pathway | WP_GPR40_PATHWAY | 9.26e-06 | 15 | 132 | 4 | M39526 | |
| Pathway | REACTOME_ASPIRIN_ADME | 6.04e-05 | 45 | 132 | 5 | MM15694 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_SHIGELLA_IPAB_C_D_TO_ITGA_B_TALIN_VINCULIN_SIGNALING_PATHWAY | 6.47e-05 | 9 | 132 | 3 | M47725 | |
| Pathway | REACTOME_SENSORY_PROCESSING_OF_SOUND | 8.27e-05 | 77 | 132 | 6 | M41822 | |
| Pubmed | Identification of a novel actin isoform in hepatocellular carcinoma. | 9.04e-09 | 15 | 176 | 5 | 16824795 | |
| Pubmed | Impact of altered actin gene expression on vinculin, talin, cell spreading, and motility. | 1.27e-07 | 3 | 176 | 3 | 7646816 | |
| Pubmed | 1.27e-07 | 3 | 176 | 3 | 36011023 | ||
| Pubmed | Silencing of nodal modulator 1 inhibits the differentiation of P19 cells into cardiomyocytes. | 1.27e-07 | 3 | 176 | 3 | 25576386 | |
| Pubmed | LCP1 preferentially binds clasped αMβ2 integrin and attenuates leukocyte adhesion under flow. | FLNA ACTG1 MCM2 PFAS SMC2 NOMO1 NOMO2 SUPT16H HELZ2 SEPTIN11 NOMO3 VCL | 2.14e-07 | 344 | 176 | 12 | 30333137 |
| Pubmed | 5.08e-07 | 4 | 176 | 3 | 20976199 | ||
| Pubmed | Establishment of a conditional Nomo1 mouse model by CRISPR/Cas9 technology. | 5.08e-07 | 4 | 176 | 3 | 31833031 | |
| Pubmed | 5.08e-07 | 4 | 176 | 3 | 9267806 | ||
| Pubmed | 7.49e-07 | 62 | 176 | 6 | 15862967 | ||
| Pubmed | 2.52e-06 | 6 | 176 | 3 | 12679033 | ||
| Pubmed | 3.32e-06 | 234 | 176 | 9 | 36243803 | ||
| Pubmed | 4.39e-06 | 7 | 176 | 3 | 16059920 | ||
| Pubmed | Nicalin and its binding partner Nomo are novel Nodal signaling antagonists. | 7.00e-06 | 8 | 176 | 3 | 15257293 | |
| Pubmed | ABHD17A FLNA ATP7B ACLY HTATIP2 KATNB1 ACTB RNF149 ACTG1 EXT2 OPA1 LCLAT1 NOMO1 NUP205 ADIPOR1 MTOR DDX54 HELZ2 ATG9A | 8.18e-06 | 1168 | 176 | 19 | 19946888 | |
| Pubmed | ATRX promotes heterochromatin formation to protect cells from G-quadruplex DNA-mediated stress. | 8.69e-06 | 26 | 176 | 4 | 34162889 | |
| Pubmed | 8.69e-06 | 26 | 176 | 4 | 23382103 | ||
| Pubmed | ANK2 CYTH2 ACTB DPYSL4 ZNFX1 SMC2 ADNP OPA1 KIAA0319 AKAP9 SSH1 MTOR SUPT16H SYN1 SEPTIN11 PLCL1 RASAL2 | 8.85e-06 | 963 | 176 | 17 | 28671696 | |
| Pubmed | A Human Tyrosine Phosphatase Interactome Mapped by Proteomic Profiling. | FLNA CAND2 ACLY DHX40 MCM2 PFAS EXT2 SMC2 OPA1 NOMO1 NUP205 DUSP26 SSH1 TELO2 MTOR DDX54 VCL | 1.02e-05 | 974 | 176 | 17 | 28675297 |
| Pubmed | 1.05e-05 | 9 | 176 | 3 | 22511988 | ||
| Pubmed | 1.05e-05 | 9 | 176 | 3 | 1339448 | ||
| Pubmed | Substrate-driven assembly of a translocon for multipass membrane proteins. | 1.05e-05 | 9 | 176 | 3 | 36261522 | |
| Pubmed | 1.24e-05 | 100 | 176 | 6 | 21800051 | ||
| Pubmed | 1.49e-05 | 10 | 176 | 3 | 23642732 | ||
| Pubmed | 1.49e-05 | 10 | 176 | 3 | 11465080 | ||
| Pubmed | 1.49e-05 | 10 | 176 | 3 | 23371916 | ||
| Pubmed | A genome-wide association study of total bilirubin and cholelithiasis risk in sickle cell anemia. | 1.49e-05 | 10 | 176 | 3 | 22558097 | |
| Pubmed | Hepatic lipase maturation: a partial proteome of interacting factors. | 1.79e-05 | 31 | 176 | 4 | 19136429 | |
| Pubmed | 2.04e-05 | 11 | 176 | 3 | 14597672 | ||
| Pubmed | An ER translocon for multi-pass membrane protein biogenesis. | 2.04e-05 | 11 | 176 | 3 | 32820719 | |
| Pubmed | Beta- and gamma-cytoplasmic actins are required for meiosis in mouse oocytes. | 2.55e-05 | 2 | 176 | 2 | 21778137 | |
| Pubmed | De novo mutations in the actin genes ACTB and ACTG1 cause Baraitser-Winter syndrome. | 2.55e-05 | 2 | 176 | 2 | 22366783 | |
| Pubmed | 2.55e-05 | 2 | 176 | 2 | 8068691 | ||
| Pubmed | Regulation of mTOR by polycystin-1: is polycystic kidney disease a case of futile repair? | 2.55e-05 | 2 | 176 | 2 | 17102641 | |
| Pubmed | Prenatal presentation and diagnosis of Baraitser-Winter syndrome using exome sequencing. | 2.55e-05 | 2 | 176 | 2 | 32588558 | |
| Pubmed | 2.55e-05 | 2 | 176 | 2 | 27625340 | ||
| Pubmed | 2.55e-05 | 2 | 176 | 2 | 24641623 | ||
| Pubmed | 2.55e-05 | 2 | 176 | 2 | 25808902 | ||
| Pubmed | 2.55e-05 | 2 | 176 | 2 | 11207030 | ||
| Pubmed | A primate-specific POTE-actin fusion protein plays a role in apoptosis. | 2.55e-05 | 2 | 176 | 2 | 19669888 | |
| Pubmed | 2.55e-05 | 2 | 176 | 2 | 3221869 | ||
| Pubmed | The T cell receptor from an influenza-A specific murine CTL clone. | 2.55e-05 | 2 | 176 | 2 | 2784852 | |
| Pubmed | 2.55e-05 | 2 | 176 | 2 | 11919560 | ||
| Pubmed | Characterization of the common genetic defect in humans deficient in debrisoquine metabolism. | 2.55e-05 | 2 | 176 | 2 | 3123997 | |
| Pubmed | 2.55e-05 | 2 | 176 | 2 | 21502360 | ||
| Pubmed | 2.55e-05 | 2 | 176 | 2 | 6686106 | ||
| Pubmed | 2.55e-05 | 2 | 176 | 2 | 213279 | ||
| Pubmed | 2.55e-05 | 2 | 176 | 2 | 33334799 | ||
| Pubmed | 2.55e-05 | 2 | 176 | 2 | 37189200 | ||
| Pubmed | 2.55e-05 | 2 | 176 | 2 | 27748889 | ||
| Pubmed | β-Actin specifically controls cell growth, migration, and the G-actin pool. | 2.55e-05 | 2 | 176 | 2 | 21900491 | |
| Pubmed | 2.55e-05 | 2 | 176 | 2 | 19659929 | ||
| Pubmed | 2.55e-05 | 2 | 176 | 2 | 29053796 | ||
| Pubmed | Beta and gamma-cytoplasmic actins display distinct distribution and functional diversity. | 2.55e-05 | 2 | 176 | 2 | 19638415 | |
| Pubmed | 2.55e-05 | 2 | 176 | 2 | 17967520 | ||
| Pubmed | Botulinum C2 toxin ADP-ribosylates cytoplasmic beta/gamma-actin in arginine 177. | 2.55e-05 | 2 | 176 | 2 | 3335520 | |
| Pubmed | 2.55e-05 | 2 | 176 | 2 | 9288906 | ||
| Pubmed | 2.55e-05 | 2 | 176 | 2 | 1577857 | ||
| Pubmed | Characterization of Cyp2d22, a novel cytochrome P450 expressed in mouse mammary cells. | 2.55e-05 | 2 | 176 | 2 | 11032406 | |
| Pubmed | 2.55e-05 | 2 | 176 | 2 | 21543106 | ||
| Pubmed | 2.55e-05 | 2 | 176 | 2 | 26583190 | ||
| Pubmed | 2.55e-05 | 2 | 176 | 2 | 32326615 | ||
| Pubmed | Severe forms of Baraitser-Winter syndrome are caused by ACTB mutations rather than ACTG1 mutations. | 2.55e-05 | 2 | 176 | 2 | 23756437 | |
| Pubmed | Vinculin and metavinculin: oligomerization and interactions with F-actin. | 2.55e-05 | 2 | 176 | 2 | 23466368 | |
| Pubmed | Pathogenicity analysis of novel variations in Chinese Han patients with polycystic kidney disease. | 2.55e-05 | 2 | 176 | 2 | 28578020 | |
| Pubmed | 2.55e-05 | 2 | 176 | 2 | 34202629 | ||
| Pubmed | Cytochalasin D-induced actin gene expression in murine erythroleukemia cells. | 2.55e-05 | 2 | 176 | 2 | 8482333 | |
| Pubmed | 2.55e-05 | 2 | 176 | 2 | 29265728 | ||
| Pubmed | Multi-isotope imaging mass spectrometry reveals slow protein turnover in hair-cell stereocilia. | 2.55e-05 | 2 | 176 | 2 | 22246323 | |
| Pubmed | A conserved sequence in the T-cell receptor beta-chain promoter region. | 2.55e-05 | 2 | 176 | 2 | 3259318 | |
| Pubmed | 2.55e-05 | 2 | 176 | 2 | 19594327 | ||
| Pubmed | 2.55e-05 | 2 | 176 | 2 | 2837653 | ||
| Pubmed | Coding-noncoding gene expression in intrahepatic cholangiocarcinoma. | 2.55e-05 | 2 | 176 | 2 | 26297049 | |
| Pubmed | 2.55e-05 | 2 | 176 | 2 | 32349449 | ||
| Pubmed | Baraitser-Winter cerebrofrontofacial syndrome: Report of two adult siblings. | 2.55e-05 | 2 | 176 | 2 | 32506774 | |
| Pubmed | Differential arginylation of actin isoforms is regulated by coding sequence-dependent degradation. | 2.55e-05 | 2 | 176 | 2 | 20847274 | |
| Pubmed | 2.55e-05 | 2 | 176 | 2 | 15051713 | ||
| Pubmed | 2.55e-05 | 2 | 176 | 2 | 14570768 | ||
| Pubmed | 2.71e-05 | 12 | 176 | 3 | 19419973 | ||
| Pubmed | Thirteen UDPglucuronosyltransferase genes are encoded at the human UGT1 gene complex locus. | 2.71e-05 | 12 | 176 | 3 | 11434514 | |
| Pubmed | 2.91e-05 | 70 | 176 | 5 | 20301607 | ||
| Pubmed | FLNA EPPK1 ACLY PFAS ADNP TTF1 NUP205 MTOR DDX54 HELZ2 WDR12 VCL PNP | 3.11e-05 | 653 | 176 | 13 | 22586326 | |
| Pubmed | FLNA EPPK1 GTPBP6 ACLY ACTB RNF149 ACTG1 MCM2 EXT2 FAT1 NOMO2 PAFAH1B1 SEPTIN11 CERCAM WDR12 ATG9A PNP SORD HELLS | 3.46e-05 | 1297 | 176 | 19 | 33545068 | |
| Pubmed | UGT1A1 is a major locus influencing bilirubin levels in African Americans. | 3.51e-05 | 13 | 176 | 3 | 22085899 | |
| Pubmed | Genome-wide analysis of hepatic lipid content in extreme obesity. | 3.51e-05 | 13 | 176 | 3 | 25246029 | |
| Pubmed | 4.45e-05 | 14 | 176 | 3 | 21646302 | ||
| Pubmed | Human UDP-glucuronosyltransferases: metabolism, expression, and disease. | 4.45e-05 | 14 | 176 | 3 | 10836148 | |
| Pubmed | 4.45e-05 | 14 | 176 | 3 | 9295054 | ||
| Pubmed | Multiple variable first exons: a mechanism for cell- and tissue-specific gene regulation. | 4.45e-05 | 14 | 176 | 3 | 14672974 | |
| Pubmed | FLNA ANK2 GTPBP6 PCDHGA7 POTEF ACTB ACTG1 REL SMC2 SLC30A2 SLC4A3 RYR2 NUP205 SPATC1 POTEE SLC22A14 SUPT16H PKHD1 POTEI PLCH1 | 4.57e-05 | 1442 | 176 | 20 | 35575683 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | DOCK3 FLNA CRYBG2 MGAT4B EPPK1 GTPBP6 PFAS MIB2 TXNRD2 GDPD5 FAT1 SSH1 MTOR PKD1 HELZ2 HMGXB3 ATG9A | 5.02e-05 | 1105 | 176 | 17 | 35748872 |
| Pubmed | SRF phosphorylation by glycogen synthase kinase-3 promotes axon growth in hippocampal neurons. | 5.54e-05 | 15 | 176 | 3 | 24623780 | |
| Pubmed | Mouse screen reveals multiple new genes underlying mouse and human hearing loss. | THEMIS2 ABHD17A CAND2 CDH23 ISG20 TGM6 DUSP26 SMYD4 AKAP9 MTOR WFIKKN2 TRAPPC10 HMGXB3 CFAP61 MYO15A SLC25A28 MTRF1L RASAL2 | 6.44e-05 | 1242 | 176 | 18 | 30973865 |
| Pubmed | CAND2 ACTB PFAS OPA1 NOMO1 SORT1 TELO2 NOMO2 MTOR PANK4 DDX54 NOMO3 | 6.63e-05 | 606 | 176 | 12 | 36538041 | |
| Pubmed | Genome-wide association meta-analysis for total serum bilirubin levels. | 6.80e-05 | 16 | 176 | 3 | 19414484 | |
| Pubmed | 7.61e-05 | 3 | 176 | 2 | 31251475 | ||
| Pubmed | Molecular characterization of abLIM, a novel actin-binding and double zinc finger protein. | 7.61e-05 | 3 | 176 | 2 | 9245787 | |
| Pubmed | WNK4 enhances the degradation of NCC through a sortilin-mediated lysosomal pathway. | 7.61e-05 | 3 | 176 | 2 | 19875813 | |
| Pubmed | Characterization of PKD protein-positive exosome-like vesicles. | 7.61e-05 | 3 | 176 | 2 | 19158352 | |
| Pubmed | 7.61e-05 | 3 | 176 | 2 | 1532150 | ||
| Pubmed | Angiostatin and plasminogen share binding to endothelial cell surface actin. | 7.61e-05 | 3 | 176 | 2 | 15746964 | |
| Interaction | SHBG interactions | 1.79e-06 | 69 | 169 | 7 | int:SHBG | |
| Interaction | ACTG2 interactions | 3.30e-06 | 49 | 169 | 6 | int:ACTG2 | |
| Interaction | SCIN interactions | 8.98e-06 | 58 | 169 | 6 | int:SCIN | |
| GeneFamily | Cadherin related | 4.39e-06 | 17 | 122 | 4 | 24 | |
| GeneFamily | Ankyrin repeat domain containing|POTE ankyrin domain containing | 8.16e-05 | 13 | 122 | 3 | 685 | |
| GeneFamily | Phospholipases|C2 domain containing phospholipases | 2.68e-04 | 19 | 122 | 3 | 832 | |
| GeneFamily | Actins | 6.66e-04 | 6 | 122 | 2 | 929 | |
| GeneFamily | Blood group antigens|CD molecules|I-set domain containing|Immunoglobulin like domain containing | 7.85e-04 | 161 | 122 | 6 | 593 | |
| GeneFamily | Actins|Deafness associated genes | 1.01e-03 | 113 | 122 | 5 | 1152 | |
| GeneFamily | Ankyrin repeat domain containing | 1.28e-03 | 242 | 122 | 7 | 403 | |
| GeneFamily | UDP glucuronosyltransferases | 1.29e-03 | 32 | 122 | 3 | 363 | |
| GeneFamily | UPF1 like RNA helicases | 2.39e-03 | 11 | 122 | 2 | 1169 | |
| Coexpression | GSE37301_PRO_BCELL_VS_GRANULOCYTE_MONOCYTE_PROGENITOR_DN | 2.73e-06 | 175 | 174 | 9 | M8892 | |
| ToppCell | COVID-19-Heart-CM_+_EC_+_Pericyte|Heart / Disease (COVID-19 only), tissue and cell type | 7.99e-08 | 193 | 176 | 9 | dd5378a1ef8eb0eda9a3aae62f3c2f3a1402bda0 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.27e-07 | 184 | 176 | 8 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.27e-07 | 184 | 176 | 8 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.27e-07 | 184 | 176 | 8 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | RV-04._Ventricular_Cardiomyocyte_I|RV / Chamber and Cluster_Paper | 8.90e-07 | 189 | 176 | 8 | 9c1debd65c13d63fd4f3158917d621b44b714c26 | |
| ToppCell | Smart-start-Cell-Wel_seq-Neoplastic-Stem-like-OPC-like-OPC-like-F|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.04e-06 | 193 | 176 | 8 | 315840bc48899f3a36d57b19197509de19716e3d | |
| ToppCell | PND14-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_T-CD4_T-CD4_T_prolif|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.29e-06 | 150 | 176 | 7 | 7bc61eb4b8c4a1909f4b7bcd1c6a88ef46102669 | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-24m-Neuronal-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.07e-06 | 178 | 176 | 7 | 1bddbc083c36657bd6910f7466126ab325e88176 | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-24m-Neuronal-neuron|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.07e-06 | 178 | 176 | 7 | a74e5a390cbeaca9de1fdb7b2a0e50783bd202dd | |
| ToppCell | LPS_only|World / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 9.09e-06 | 185 | 176 | 7 | a72ccb147ca505880e2da8f6a70b9d570464a691 | |
| ToppCell | Thalamus-Neuronal-Excitatory-eN2(Slc17a7_Slc17a6)-Slc17a6|Thalamus / BrainAtlas - Mouse McCarroll V32 | 9.14e-06 | 71 | 176 | 5 | 7623b110bc3db0f5b99803c8fbb881ae8846b817 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c05-ZNF683|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 9.75e-06 | 187 | 176 | 7 | 8c69fd469df2915c56ede534cee3ef23d5f64ebf | |
| ToppCell | IPF-Myeloid-cDC1|Myeloid / Disease state, Lineage and Cell class | 1.01e-05 | 188 | 176 | 7 | 47bb6caf84f70a1cda7d09803afdfd5182772e66 | |
| ToppCell | Control-PLT_3|World / Disease Group and Platelet Clusters | 1.04e-05 | 189 | 176 | 7 | f65c261fe25479e900d5ed1a0d25a9dec302a57b | |
| ToppCell | PBMC-Severe-cDC_12|Severe / Compartment, Disease Groups and Clusters | 1.08e-05 | 190 | 176 | 7 | 84ee185939bdefb10705b621a70da27701eadcee | |
| ToppCell | PBMC-Mild|PBMC / Compartment, Disease Groups and Clusters | 1.24e-05 | 194 | 176 | 7 | d1366b169d14011194e61d16b6b0953349febc78 | |
| ToppCell | COVID-19-Heart-CM_1|Heart / Disease (COVID-19 only), tissue and cell type | 1.28e-05 | 195 | 176 | 7 | f1ef50331eda8f1239dba6ea970df4eaccf032f1 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_ILC-NK_cell-NK_c01-FCGR3A|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.37e-05 | 197 | 176 | 7 | f84263c5aaf3a5cd46d6e06358e8de6c6e6eaa3b | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-TAM-MG-TAM-MG_pro-infl_II-F|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.37e-05 | 197 | 176 | 7 | b597c292fc1cb381a4325fed15a32966c38def28 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d14-21-Lymphocytic-Lymphocytic_ILC|Severe-critical_convalescent_d14-21 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.41e-05 | 198 | 176 | 7 | 716c27d2a37b5f865b9d191e1851917340b400af | |
| ToppCell | PBMC-Severe-Lymphocyte-B-Plasmablast-Plasmablast-Developping_Plasmablast|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.41e-05 | 198 | 176 | 7 | 2d8d4eb21b4fe3cc178b3518b3ea39c2d9650f24 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d14-21-Lymphocytic-Lymphocytic_ILC-NK_cell|Severe-critical_convalescent_d14-21 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.41e-05 | 198 | 176 | 7 | b12914c3c5b8dd628cb456cb40283c5016641872 | |
| ToppCell | mild-Lymphocytic-NK_cells|mild / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 1.41e-05 | 198 | 176 | 7 | dce3c008757786aa6bd4a869456b76b4cbbb1d5b | |
| ToppCell | (2)_NK/T-(20)_NK_cell|(2)_NK/T / immune cells in Peripheral Blood (logTPM normalization) | 1.41e-05 | 198 | 176 | 7 | 2e4851e49457940e841660c5d781499ffb4a2bf1 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d14-21-Lymphocytic-Lymphocytic_ILC-NK_cell-NK_c01-FCGR3A|Severe-critical_convalescent_d14-21 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.41e-05 | 198 | 176 | 7 | 1a189b2b213099505c5d871fb8aedd55a97d44e0 | |
| ToppCell | (2)_NK/T-(200)_CD56+_NK_cell|(2)_NK/T / immune cells in Peripheral Blood (logTPM normalization) | 1.41e-05 | 198 | 176 | 7 | 03477a6356a3c08c6e723165c0aac3464ef01667 | |
| ToppCell | LPS_only-Hematopoietic_Lymphocytic-Lymphocytic_NK/T-iNKT-MAIT|LPS_only / Treatment groups by lineage, cell group, cell type | 1.46e-05 | 199 | 176 | 7 | b62a756b5472972156d05051a58671a58bef1f16 | |
| ToppCell | CD8+_Memory_T_cell-CV-2|CD8+_Memory_T_cell / cell class, Virus stimulation and cluster | 1.46e-05 | 199 | 176 | 7 | 1e33d8e2e0d6a54ef6e2e13f986e19fd209275a8 | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_myocytic-Pericyte-Pericyte_3|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 1.51e-05 | 200 | 176 | 7 | c06426f877919bdd267ea2fd7e7973c6619832ae | |
| ToppCell | Kidney|World / Skin and Kidney Cells in Lupus Nephritis Patients. | 1.51e-05 | 200 | 176 | 7 | 1f99afa1f3c32a2a9cfb4ad33ff4d404e34fac63 | |
| ToppCell | PBMC-Severe-cDC_1|Severe / Compartment, Disease Groups and Clusters | 1.74e-05 | 81 | 176 | 5 | 6d1e524f000b71c935359afc801a1d31f218fec8 | |
| ToppCell | E17.5-Hematopoietic-Erythroid|E17.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.85e-05 | 82 | 176 | 5 | e0b12b9fb3cd56902b068dc0d921241481aa70a9 | |
| ToppCell | E17.5-Hematopoietic-Erythroid-enucleate_erythrocyte|E17.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.85e-05 | 82 | 176 | 5 | 8917c6fd4a6e3cb7a3a2af489ccc3fdc55c26698 | |
| ToppCell | LPS-IL1RA+antiTNF-Endothelial-Epi-like|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.17e-05 | 142 | 176 | 6 | a05b320cf182b2aaf18df7c40045dc65b659bf20 | |
| ToppCell | LPS-IL1RA+antiTNF-Endothelial-Epi-like-Gen_Cap|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.17e-05 | 142 | 176 | 6 | d52da766e031f7409eb5a7a9fa88f48e14a79d8b | |
| ToppCell | pdx-Tumor_cells-T9|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 2.35e-05 | 144 | 176 | 6 | 0b94d978262a826c9254145aa98c6c30240243f9 | |
| ToppCell | BLOOD--(0)_NK_cell-(0)_NK_cells_(CD56dim-like)|(0)_NK_cell / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 2.44e-05 | 145 | 176 | 6 | 6dd81d53d006fcc206a10969374a11c372f92133 | |
| ToppCell | facs-Lung-Endomucin-24m-Endothelial-Capillary_Type_1_Cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.44e-05 | 145 | 176 | 6 | 96712c68ab759d7ade0d912581a1a7c25dc6def8 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_ILC-NK_cell-NK_c01-FCGR3A|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.30e-05 | 153 | 176 | 6 | 4eb9c2d7e4b95d44198fc87dc115a08ef0153e26 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_ILC-NK_cell|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.30e-05 | 153 | 176 | 6 | 26b5b45c117d155b028d298a0b93e16d343dca97 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_ILC|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.30e-05 | 153 | 176 | 6 | 0f12e38f2cbf69a520764289b0aa4dedc645f714 | |
| ToppCell | PND14-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_ILC-NK-NK-NK_prolif|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.09e-05 | 159 | 176 | 6 | 95128a2367ff2a639b21913c0350924c174faef8 | |
| ToppCell | PND10-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_ILC-NK-ILC|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.09e-05 | 159 | 176 | 6 | 5c7a099aa84ecc62bf9b5e1609e5b6b77889f175 | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.24e-05 | 160 | 176 | 6 | c381ec6be8cf887861cc18f831a20db42f953fe1 | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-pre_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.24e-05 | 160 | 176 | 6 | 25c8f3d2a6d14ff0ca0b965fce89d3ff22f40585 | |
| ToppCell | BAL-Control-Myeloid-cDC-cDC-cDC_12|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 4.39e-05 | 161 | 176 | 6 | 1670108afc0af90861eb80a84e59995571c0da1b | |
| ToppCell | BAL-Control-Myeloid-cDC-cDC-cDC_12|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 4.39e-05 | 161 | 176 | 6 | 1d446f5ba57d84949823a35cbedaee8f448fe40f | |
| ToppCell | facs-Pancreas-Exocrine-24m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.86e-05 | 164 | 176 | 6 | b895674ed2df87db8fbfb30b7e31620945588491 | |
| ToppCell | 15-Airway-Mesenchymal-Airway_Smooth_Muscle|Airway / Age, Tissue, Lineage and Cell class | 5.03e-05 | 165 | 176 | 6 | 531804467601e1ee1f771cffa21501f6d464ae10 | |
| ToppCell | Cerebellum-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)|Cerebellum / BrainAtlas - Mouse McCarroll V32 | 5.38e-05 | 167 | 176 | 6 | 9efb9511a211d0824bb97f82c1a5860c43d2138f | |
| ToppCell | Cerebellum-Neuronal-Inhibitory|Cerebellum / BrainAtlas - Mouse McCarroll V32 | 5.38e-05 | 167 | 176 | 6 | 904c613aac3f9919a432b110bb1dcc832b5aec0a | |
| ToppCell | facs-Lung-EPCAM-18m-Lymphocytic-plasma_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.75e-05 | 169 | 176 | 6 | e348d9877a1bcad4f33dd7b2ce6cb0049583c4d2 | |
| ToppCell | facs-Lung-EPCAM-18m-Lymphocytic-Plasma_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.75e-05 | 169 | 176 | 6 | 3167ca0c826244280e0e07d1e02656cf5e4e75a5 | |
| ToppCell | E18.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-PMP-PMP_prolif|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.94e-05 | 170 | 176 | 6 | b1a16600754e0c12f7d39c9221f1b03135833f16 | |
| ToppCell | COVID-19-Heart-CM_+_Macrophage|COVID-19 / Disease (COVID-19 only), tissue and cell type | 5.94e-05 | 170 | 176 | 6 | 3f15242a1d3e4e9871d9170b2ef05842fb609c29 | |
| ToppCell | droplet-Lung-immune-endo-depleted-3m-Lymphocytic-Proliferating_NK|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.13e-05 | 171 | 176 | 6 | 1eebd7138c3b20ddc1104f21615f9df0e776bbe6 | |
| ToppCell | 356C-Lymphocytic-CD4_T-cell-CD4+_Effector_T_cell-2|CD4_T-cell / Donor, Lineage, Cell class and subclass (all cells) | 6.13e-05 | 171 | 176 | 6 | bdd30100b74e012eec3090799c22635aa57fa91d | |
| ToppCell | Thalamus-Neuronal-Excitatory-eN2(Slc17a7_Slc17a6)-Slc17a6-Excitatory_Neuron.Slc17a6.Nrgn_(Habenula_(inferomedial_and_lateral))-|Thalamus / BrainAtlas - Mouse McCarroll V32 | 6.14e-05 | 54 | 176 | 4 | c74878f5c7a20aeb813cc8f05a71216262c4dcad | |
| ToppCell | Thalamus-Neuronal-Excitatory-eN2(Slc17a7_Slc17a6)-Slc17a6-Excitatory_Neuron.Slc17a6.Nrgn_(Habenula_(inferomedial_and_lateral))|Thalamus / BrainAtlas - Mouse McCarroll V32 | 6.14e-05 | 54 | 176 | 4 | a2669b3f714c50fd51f7f32ea893282333f6ddac | |
| ToppCell | P15-Mesenchymal-developing_mesenchymal_cell-mesenchymal_proliferating_cell|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 6.33e-05 | 172 | 176 | 6 | 7c238a7375341d4647ba7274d93fddfb6fae7ce4 | |
| ToppCell | droplet-Kidney-nan-18m-Lymphocytic-CD45____plasma_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.54e-05 | 173 | 176 | 6 | 60e427f6c7d953cef5f692043670ff0b49cdce72 | |
| ToppCell | PND28-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.75e-05 | 174 | 176 | 6 | c6087fd0e036ec7f40f0f8f17d1f6ce13ddb5235 | |
| ToppCell | droplet-Kidney-nan-18m-Lymphocytic-plasma_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.75e-05 | 174 | 176 | 6 | c92eec5a14ca5269673582dd115ead8516e64c3e | |
| ToppCell | PND28-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC-EPC_G2M|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.75e-05 | 174 | 176 | 6 | 72df66319f6efbd88ecf439013d97409fbf3cb52 | |
| ToppCell | droplet-Marrow-nan-18m-Myeloid-basophil|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.75e-05 | 174 | 176 | 6 | 55cc8300489d11322724159ec7d0e1d32a702e91 | |
| ToppCell | Adult-Epithelial-lung_neuroendocrine_cell_(PNEC)-D231|Adult / Lineage, Cell type, age group and donor | 6.97e-05 | 175 | 176 | 6 | 8d9f44a2633b71fb4d2b4a7d9530f954e07c4a18 | |
| ToppCell | Adult-Epithelial-lung_neuroendocrine_cell_(PNEC)|Adult / Lineage, Cell type, age group and donor | 6.97e-05 | 175 | 176 | 6 | 4db1a3c284488b3f6de7568363f176d74e2a4587 | |
| ToppCell | 390C-Fibroblasts-Fibroblast-B_(Myofibroblast)|390C / Donor, Lineage, Cell class and subclass (all cells) | 7.19e-05 | 176 | 176 | 6 | 852d3da0907fe87c0ef23d75a63ce07619cf0c54 | |
| ToppCell | 390C-Fibroblasts-Fibroblast-B_(Myofibroblast)-|390C / Donor, Lineage, Cell class and subclass (all cells) | 7.19e-05 | 176 | 176 | 6 | d2df1e435996c51213e88270af9f928e9e09a6f5 | |
| ToppCell | 3'_v3-blood-Lymphocytic_B_plasma-Plasmablasts|blood / Manually curated celltypes from each tissue | 7.90e-05 | 179 | 176 | 6 | 7d3bd1f9e126a4a9e0a84720a6cc0b3d235e65ee | |
| ToppCell | wk_15-18-Endothelial-Blood_vessel_endothelial-OMD+_endo|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 7.90e-05 | 179 | 176 | 6 | 8c9ed247e1c4d655b81ce2f24a9936a7cade718a | |
| ToppCell | Smart-seq2-blood_(Smart-seq2)-hematologic-thrombocytic|blood_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 8.14e-05 | 180 | 176 | 6 | fb3d549c2a69b2157a486786ddd775ca16699ed0 | |
| ToppCell | systemic_lupus_erythematosus-flare-Lymphocytic_B-B_plasma-male|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 8.14e-05 | 180 | 176 | 6 | 8e96f8646c002768b272359af485dc0ab57e0ccd | |
| ToppCell | Smart-seq2-blood_(Smart-seq2)-hematologic-thrombocytic-platelet|blood_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 8.14e-05 | 180 | 176 | 6 | beb4d777e0c5fa0a59672dbc3dbb7732498605ff | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte-Pericyte_prolif|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 8.39e-05 | 181 | 176 | 6 | 274c0b768925cd5804483303f8c5ebd17a534c41 | |
| ToppCell | Control-Myeloid-DC1|Control / Condition, Lineage and Cell class | 8.39e-05 | 181 | 176 | 6 | 5a2a1f017ad23baed9972c68b4a46f4c618ef21a | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast-Myofibroblasts-Myofibroblasts_L.2.3.2.2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.39e-05 | 181 | 176 | 6 | b116c68393d8836bac080f81a8fcbeb52e0403e7 | |
| ToppCell | COVID-19-Heart-CM_+_EC_+_Pericyte|COVID-19 / Disease (COVID-19 only), tissue and cell type | 8.39e-05 | 181 | 176 | 6 | 719eb532453ab7cd7893726885bc75d74a10b21e | |
| ToppCell | 343B-Lymphocytic-NK_cells-NK_cell_D|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 8.65e-05 | 182 | 176 | 6 | c6172aca2475bf0948a78e39f0dae6388504a915 | |
| ToppCell | COVID-19-Heart-CM_3|Heart / Disease (COVID-19 only), tissue and cell type | 8.65e-05 | 182 | 176 | 6 | 287fcc3897ae08841f6f85ae6c9cef16f75b1dd1 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-myofibroblast_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 8.65e-05 | 182 | 176 | 6 | ed6ae0fd8653f213fe29906a6a4e0729a62e1b75 | |
| ToppCell | B_cells-ISG-high_B_cells|World / Immune cells in Kidney/Urine in Lupus Nephritis | 8.92e-05 | 183 | 176 | 6 | dc2b00e920efa1dcc2a6265cd1024e3249c9974f | |
| ToppCell | Control-Myeloid-DC1|Myeloid / Condition, Lineage and Cell class | 9.19e-05 | 184 | 176 | 6 | b5c1f57f0356969cfb0e1dac764684fc5583bc04 | |
| ToppCell | Control-Myeloid-cDC1|Myeloid / Disease state, Lineage and Cell class | 9.19e-05 | 184 | 176 | 6 | c6affa0b12510363258f65e46bf2d47bf4a8e75f | |
| ToppCell | COPD-Myeloid-cDC1|World / Disease state, Lineage and Cell class | 9.19e-05 | 184 | 176 | 6 | 42d7ce104cd7bcb83fbbbd0e7d3267ad07edfa94 | |
| ToppCell | COVID-19-Heart-CM_1|COVID-19 / Disease (COVID-19 only), tissue and cell type | 9.19e-05 | 184 | 176 | 6 | e737f0f14c49b07bbb04a165083ac32210bc5690 | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_COL13A1^pos_fibro2_(5)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 9.47e-05 | 185 | 176 | 6 | 1ac6a32cc56d5d819649bdd99518e2ead0eead4c | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_1-D175|Adult / Lineage, Cell type, age group and donor | 9.47e-05 | 185 | 176 | 6 | 32b4e68e551d435a732f253f6ad83408c759a642 | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_COL13A1^pos_fibro2_(5)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 9.75e-05 | 186 | 176 | 6 | 7def03dd856b765bd3f493288641981c4f7fd26e | |
| ToppCell | AT1_cells-SSc-ILD_01|World / lung cells shred on cell class, cell subclass, sample id | 1.00e-04 | 187 | 176 | 6 | f1dda349335e08dbfc8395d373924037f5ad2fd6 | |
| ToppCell | 3'-Adult-LargeIntestine-Hematopoietic-Myeloid-Lymphoid_DC|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.00e-04 | 187 | 176 | 6 | d69f4eee0304a7db226275ab77fc9d5d2b6f3a07 | |
| ToppCell | RV-04._Ventricular_Cardiomyocyte_I|World / Chamber and Cluster_Paper | 1.00e-04 | 187 | 176 | 6 | 78cdcf8bc141d3b155c3c8af908431fc419c4d08 | |
| ToppCell | LA-13._Vascular_Smooth_Muscle|LA / Chamber and Cluster_Paper | 1.03e-04 | 188 | 176 | 6 | 34e1b074a3995aa46ab194eb45115d76d1a5514d | |
| ToppCell | Fetal_29-31_weeks-Epithelial-lung_neuroendocrine_cell_(PNEC)-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.03e-04 | 188 | 176 | 6 | c4c3b21ab723b0e9beff9ec84f8d68485f771528 | |
| ToppCell | COPD-Stromal-SMC|Stromal / Disease state, Lineage and Cell class | 1.03e-04 | 188 | 176 | 6 | 9ffef4b01d0ddd6913c9ed6be79aeaaabd5e41ed | |
| ToppCell | 343B-Lymphocytic-NK_cells-NK_cell_B1|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 1.06e-04 | 118 | 176 | 5 | c351e465ece4f3767b2c19e695eca3c263c68777 | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Lung_smooth_muscle|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.13e-04 | 191 | 176 | 6 | 7853ac7dff649150e6ff27cd4c8cf7c1fc034ed4 | |
| ToppCell | facs-Marrow-B-cells-18m-Lymphocytic-immature_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.13e-04 | 191 | 176 | 6 | 10644258b97f9c99eb0e199b64b970f6b986aa41 | |
| ToppCell | COPD-Myeloid-cDC1|Myeloid / Disease state, Lineage and Cell class | 1.13e-04 | 191 | 176 | 6 | 3480e6d27dd4291765bbbb2acdb6a2e4f02c8085 | |
| ToppCell | facs-Marrow-B-cells-18m-Lymphocytic-immature_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.13e-04 | 191 | 176 | 6 | 408942fc8db939239aeee6ae07a21362133c9e2e | |
| Drug | N-benzylformamide | 1.10e-07 | 76 | 172 | 8 | CID000080654 | |
| Drug | 9-OH-risperidone | 2.48e-07 | 19 | 172 | 5 | CID000475100 | |
| Drug | Benzamidoxime hydrochloride | 4.28e-07 | 21 | 172 | 5 | CID000069186 | |
| Drug | tritanol | 2.13e-06 | 13 | 172 | 4 | CID000006457 | |
| Drug | p-nitroanisole | 6.34e-06 | 92 | 172 | 7 | CID000007485 | |
| Drug | 6beta-hydroxytestosterone | 8.32e-06 | 37 | 172 | 5 | CID000065543 | |
| Drug | AC1MRGT8 | 1.16e-05 | 67 | 172 | 6 | CID003517815 | |
| Drug | imipramine | GABRR2 CYP2D7 CYP2D6 TSPOAP1 UGT1A5 UGT1A4 UGT1A3 SYN1 PLCB3 PLCH1 | 1.26e-05 | 235 | 172 | 10 | CID000003696 |
| Drug | testosterone glucuronide | 1.40e-05 | 41 | 172 | 5 | CID000108192 | |
| Drug | 1h1q | 1.50e-05 | 70 | 172 | 6 | CID000001540 | |
| Drug | 3,4-dihydroxymethamphetamine | 2.31e-05 | 8 | 172 | 3 | CID000161126 | |
| Drug | benzyloxyresorufin | 2.79e-05 | 78 | 172 | 6 | CID000114982 | |
| Drug | AC1Q7AUJ | 3.07e-05 | 117 | 172 | 7 | CID000003303 | |
| Drug | sodium | GABRR2 ATP7B ANK2 NOX5 TRPM2 ACTB ACTG1 SLC26A9 SLC4A3 RYR2 PPM1A NOMO1 KLK4 AKAP9 KCNT2 SLC12A3 SLC26A7 MTOR PKD1 ATP4A | 3.19e-05 | 944 | 172 | 20 | CID000000923 |
| Drug | benzphetamine | 3.42e-05 | 119 | 172 | 7 | CID000002341 | |
| Drug | AC1MRQNQ | 3.44e-05 | 9 | 172 | 3 | CID003522271 | |
| Drug | DHPASiU | 3.44e-05 | 9 | 172 | 3 | CID000197602 | |
| Drug | 3-iodophenol | 3.44e-05 | 9 | 172 | 3 | CID000012272 | |
| Drug | AC1L4J7U | 3.44e-05 | 9 | 172 | 3 | CID000186631 | |
| Drug | Chebi:32663 | 3.44e-05 | 9 | 172 | 3 | CID005460873 | |
| Drug | lamotrigine | 3.51e-05 | 25 | 172 | 4 | ctd:C047781 | |
| Drug | niflumic acid | 4.69e-05 | 125 | 172 | 7 | CID000004488 | |
| Drug | tangeretin | 5.44e-05 | 54 | 172 | 5 | CID000068077 | |
| Drug | N-hydroxy-4-aminobiphenyl | 5.59e-05 | 28 | 172 | 4 | CID000081261 | |
| Drug | cupreidine | 5.67e-05 | 2 | 172 | 2 | CID000051196 | |
| Drug | afloqualone | 5.67e-05 | 2 | 172 | 2 | ctd:C033541 | |
| Drug | 3-methoxyphenethylamine | 5.67e-05 | 2 | 172 | 2 | CID000074866 | |
| Drug | AC1L1JAL | 6.45e-05 | 29 | 172 | 4 | CID000004954 | |
| Drug | Invader | 6.49e-05 | 56 | 172 | 5 | CID006442259 | |
| Drug | 4-nitrophenyl)imidazole | 6.69e-05 | 11 | 172 | 3 | CID000123155 | |
| Drug | AC1O5XMV | 6.69e-05 | 11 | 172 | 3 | CID006442661 | |
| Drug | thrombin receptor-activating peptide SFLLRNPNDKY | 7.39e-05 | 30 | 172 | 4 | ctd:C096900 | |
| Drug | 2-naphthol | 7.54e-05 | 93 | 172 | 6 | CID000008663 | |
| Drug | morphine hydrochloride | GABRR2 CYP2D7 CYP2D6 TSPOAP1 ACLY UGT1A5 RGS9 SORT1 UGT1A4 UGT1A3 SYN1 PLCB3 CMKLR1 | 7.85e-05 | 481 | 172 | 13 | CID000004253 |
| Drug | ethoxyresorufin | 8.49e-05 | 95 | 172 | 6 | CID000003294 | |
| Drug | N-OH-DABZ | 8.87e-05 | 12 | 172 | 3 | CID000051366 | |
| Drug | 1-O-beta-D-glucopyranosyl-D-mannitol | 8.87e-05 | 12 | 172 | 3 | CID000088735 | |
| Drug | 2,4,6-TCB | 8.87e-05 | 12 | 172 | 3 | CID000037247 | |
| Drug | nonanoyl-N-methylglucamide | 8.87e-05 | 12 | 172 | 3 | CID000160090 | |
| Drug | D02861 | 8.87e-05 | 12 | 172 | 3 | CID011954281 | |
| Drug | 7,7,7-triphenylheptanoic acid | 8.87e-05 | 12 | 172 | 3 | CID000276709 | |
| Drug | aniline | 1.05e-04 | 142 | 172 | 7 | CID000006115 | |
| Drug | glycerophosphoinositol | 1.06e-04 | 62 | 172 | 5 | CID000167572 | |
| Drug | 6-methylsalicylic acid | 1.08e-04 | 33 | 172 | 4 | CID000011279 | |
| Drug | geniposide | 1.08e-04 | 33 | 172 | 4 | CID000107848 | |
| Drug | 5-azido-UDP-glucuronic acid | 1.15e-04 | 13 | 172 | 3 | CID003081279 | |
| Drug | cotinine-N-glucuronide | 1.15e-04 | 13 | 172 | 3 | CID000000411 | |
| Drug | estragole | 1.22e-04 | 34 | 172 | 4 | CID000008815 | |
| Drug | ABT-538 | 1.36e-04 | 148 | 172 | 7 | CID000005076 | |
| Drug | ammonia | CYP2D7 CYP2D6 UGT1A5 ACTB ACTG1 SLC26A9 TGM6 SLC4A3 UGT1A4 UGT1A3 PKD1 GAPDHS PNP | 1.38e-04 | 509 | 172 | 13 | CID000000222 |
| Drug | mexiletine | 1.43e-04 | 66 | 172 | 5 | CID000004178 | |
| Drug | propranolol glucuronide | 1.45e-04 | 14 | 172 | 3 | CID000119515 | |
| Drug | PCB-61 | 1.45e-04 | 14 | 172 | 3 | CID000036401 | |
| Drug | AC1L9DGV | 1.53e-04 | 36 | 172 | 4 | CID000417381 | |
| Drug | 4-(dimethylamino)benzoic acid | 1.69e-04 | 3 | 172 | 2 | CID000012092 | |
| Drug | 2,4,6-trimethylbenzaldoxime | 1.69e-04 | 3 | 172 | 2 | CID000283782 | |
| Drug | O-demethyl encainide | 1.69e-04 | 3 | 172 | 2 | CID000054736 | |
| Drug | chlorpromazine N-oxide | 1.69e-04 | 3 | 172 | 2 | CID000443037 | |
| Drug | acotiamide | 1.71e-04 | 37 | 172 | 4 | CID005282338 | |
| Drug | 2,2',3,5,5'-pentachlorobiphenyl | 1.80e-04 | 15 | 172 | 3 | CID000040469 | |
| Drug | afloqualone | 1.80e-04 | 15 | 172 | 3 | CID000002040 | |
| Drug | naphthyl sulphate | 1.80e-04 | 15 | 172 | 3 | CID000114775 | |
| Drug | coumarin-3-carboxylic acid | 1.80e-04 | 15 | 172 | 3 | CID000010752 | |
| Drug | sulforaphane nitrile | 1.80e-04 | 15 | 172 | 3 | CID000543743 | |
| Drug | trifluoperazine | 1.86e-04 | 324 | 172 | 10 | CID000005566 | |
| Drug | nitrosamine | 1.89e-04 | 70 | 172 | 5 | CID000037183 | |
| Disease | angiopoietin-related protein 1 measurement | 2.65e-06 | 18 | 164 | 4 | EFO_0801382 | |
| Disease | X-11793--oxidized bilirubin measurement | 9.25e-06 | 8 | 164 | 3 | EFO_0021260 | |
| Disease | Succinimide measurement | 9.25e-06 | 8 | 164 | 3 | EFO_0022118 | |
| Disease | X-11530 measurement | 9.25e-06 | 8 | 164 | 3 | EFO_0021249 | |
| Disease | sulfate of piperine metabolite C16H19NO3 (2) measurement | 9.25e-06 | 8 | 164 | 3 | EFO_0801034 | |
| Disease | cholelithiasis, bilirubin measurement | 9.25e-06 | 8 | 164 | 3 | EFO_0004570, EFO_0004799 | |
| Disease | X-11522 measurement | 9.25e-06 | 8 | 164 | 3 | EFO_0800696 | |
| Disease | X-10458 measurement | 9.25e-06 | 8 | 164 | 3 | EFO_0800692 | |
| Disease | X-24849 measurement | 9.25e-06 | 8 | 164 | 3 | EFO_0800909 | |
| Disease | membrane-associated progesterone receptor component 1 measurement | 9.25e-06 | 8 | 164 | 3 | EFO_0802740 | |
| Disease | X-16946 measurement | 9.25e-06 | 8 | 164 | 3 | EFO_0800766 | |
| Disease | X-11442 measurement | 1.38e-05 | 9 | 164 | 3 | EFO_0021236 | |
| Disease | X-11441 measurement | 1.38e-05 | 9 | 164 | 3 | EFO_0021235 | |
| Disease | circulating cell free DNA measurement | 1.38e-05 | 9 | 164 | 3 | EFO_0004739 | |
| Disease | sulfate of piperine metabolite C18H21NO3 (3) measurement | 1.38e-05 | 9 | 164 | 3 | EFO_0801037 | |
| Disease | sulfate of piperine metabolite C18H21NO3 (1) measurement | 1.38e-05 | 9 | 164 | 3 | EFO_0801036 | |
| Disease | X-11880 measurement | 1.38e-05 | 9 | 164 | 3 | EFO_0800698 | |
| Disease | protein-tyrosine kinase 6 measurement | 1.38e-05 | 9 | 164 | 3 | EFO_0020691 | |
| Disease | testis-specific chromodomain protein Y 1 measurement | 1.38e-05 | 9 | 164 | 3 | EFO_0802127 | |
| Disease | bilirubin measurement, response to xenobiotic stimulus | 1.38e-05 | 9 | 164 | 3 | EFO_0004570, GO_0009410 | |
| Disease | urate measurement, spine bone mineral density | 1.80e-05 | 58 | 164 | 5 | EFO_0004531, EFO_0007701 | |
| Disease | bilirubin measurement, response to tenofovir | 1.97e-05 | 10 | 164 | 3 | EFO_0004570, EFO_0009279 | |
| Disease | X-21448 measurement | 1.97e-05 | 10 | 164 | 3 | EFO_0800816 | |
| Disease | UDP-glucuronosyltransferase 1-6 measurement | 1.97e-05 | 10 | 164 | 3 | EFO_0802185 | |
| Disease | X-23974 measurement | 1.97e-05 | 10 | 164 | 3 | EFO_0800867 | |
| Disease | histidine betaine (hercynine) measurement | 2.69e-05 | 11 | 164 | 3 | EFO_0800972 | |
| Disease | X-21796 measurement | 2.69e-05 | 11 | 164 | 3 | EFO_0800825 | |
| Disease | insomnia, bilirubin measurement | 2.69e-05 | 11 | 164 | 3 | EFO_0004570, EFO_0004698 | |
| Disease | aldosterone measurement | 2.69e-05 | 11 | 164 | 3 | EFO_0010219 | |
| Disease | Baraitser-Winter syndrome | 3.07e-05 | 2 | 164 | 2 | cv:C1853623 | |
| Disease | Iris Coloboma with Ptosis, Hypertelorism, and Mental Retardation | 3.07e-05 | 2 | 164 | 2 | C1855722 | |
| Disease | Fryns-Aftimos Syndrome | 3.07e-05 | 2 | 164 | 2 | C1853623 | |
| Disease | p-cresol glucuronide measurement | 3.57e-05 | 12 | 164 | 3 | EFO_0800079 | |
| Disease | biliverdin measurement | 3.57e-05 | 12 | 164 | 3 | EFO_0021033 | |
| Disease | retinol dehydrogenase 16 measurement | 4.63e-05 | 13 | 164 | 3 | EFO_0802007 | |
| Disease | Nonsyndromic genetic hearing loss | 6.70e-05 | 76 | 164 | 5 | cv:C5680182 | |
| Disease | autosomal recessive polycystic kidney disease (implicated_via_orthology) | 8.95e-05 | 16 | 164 | 3 | DOID:0110861 (implicated_via_orthology) | |
| Disease | hormone measurement | 1.08e-04 | 84 | 164 | 5 | EFO_0004730 | |
| Disease | low density lipoprotein cholesterol measurement, body fat percentage | 1.08e-04 | 17 | 164 | 3 | EFO_0004611, EFO_0007800 | |
| Disease | autosomal dominant polycystic kidney disease (is_implicated_in) | 1.83e-04 | 4 | 164 | 2 | DOID:898 (is_implicated_in) | |
| Disease | solanidine measurement | 1.83e-04 | 4 | 164 | 2 | EFO_0800966 | |
| Disease | Nonsyndromic Hearing Loss and Deafness, Autosomal Recessive | 1.88e-04 | 51 | 164 | 4 | cv:CN043650 | |
| Disease | tissue factor measurement | 2.08e-04 | 21 | 164 | 3 | EFO_0010623 | |
| Disease | lissencephaly (is_implicated_in) | 3.04e-04 | 5 | 164 | 2 | DOID:0050453 (is_implicated_in) | |
| Disease | Familial Glucocorticoid Deficiency Type 1 | 3.04e-04 | 5 | 164 | 2 | C4049650 | |
| Disease | Arsenic Induced Polyneuropathy | 3.99e-04 | 62 | 164 | 4 | C0751852 | |
| Disease | Arsenic Encephalopathy | 3.99e-04 | 62 | 164 | 4 | C0751851 | |
| Disease | Arsenic Poisoning | 3.99e-04 | 62 | 164 | 4 | C0311375 | |
| Disease | Arsenic Poisoning, Inorganic | 3.99e-04 | 62 | 164 | 4 | C0274861 | |
| Disease | Nervous System, Organic Arsenic Poisoning | 3.99e-04 | 62 | 164 | 4 | C0274862 | |
| Disease | Schizophrenia | CYP2D6 ACTB RGS9 ADNP IL18R1 OPA1 UGT1A3 SLC26A7 MTOR HHAT PAFAH1B1 SYN1 SEPTIN11 MDGA1 | 4.37e-04 | 883 | 164 | 14 | C0036341 |
| Disease | pancreatic carcinoma | 4.41e-04 | 174 | 164 | 6 | EFO_0002618 | |
| Disease | neuropathy (implicated_via_orthology) | 4.54e-04 | 6 | 164 | 2 | DOID:870 (implicated_via_orthology) | |
| Disease | xanthurenate measurement | 5.54e-04 | 29 | 164 | 3 | EFO_0010551 | |
| Disease | sugar consumption measurement | 5.68e-04 | 120 | 164 | 5 | EFO_0010158 | |
| Disease | response to dolutegravir | 6.13e-04 | 30 | 164 | 3 | EFO_0600017 | |
| Disease | Uveoretinal Coloboma | 6.33e-04 | 7 | 164 | 2 | C4554007 | |
| Disease | Moyamoya disease (implicated_via_orthology) | 8.41e-04 | 8 | 164 | 2 | DOID:13099 (implicated_via_orthology) | |
| Disease | autosomal dominant nonsyndromic deafness 20 (implicated_via_orthology) | 8.41e-04 | 8 | 164 | 2 | DOID:0110550 (implicated_via_orthology) | |
| Disease | Baraitser-Winter syndrome 1 (implicated_via_orthology) | 8.41e-04 | 8 | 164 | 2 | DOID:0081112 (implicated_via_orthology) | |
| Disease | thoracic aortic aneurysm (implicated_via_orthology) | 8.41e-04 | 8 | 164 | 2 | DOID:14004 (implicated_via_orthology) | |
| Disease | Congenital ocular coloboma (disorder) | 1.08e-03 | 9 | 164 | 2 | C0009363 | |
| Disease | cataract (implicated_via_orthology) | 1.23e-03 | 38 | 164 | 3 | DOID:83 (implicated_via_orthology) | |
| Disease | intestinal atresia (implicated_via_orthology) | 1.34e-03 | 10 | 164 | 2 | DOID:10486 (implicated_via_orthology) | |
| Disease | Congenital neurologic anomalies | 1.34e-03 | 10 | 164 | 2 | C0497552 | |
| Disease | Cranioschisis | 1.34e-03 | 10 | 164 | 2 | C0265541 | |
| Disease | patent ductus arteriosus (implicated_via_orthology) | 1.34e-03 | 10 | 164 | 2 | DOID:13832 (implicated_via_orthology) | |
| Disease | VENTRICULAR TACHYCARDIA, CATECHOLAMINERGIC POLYMORPHIC, 1 (disorder) | 1.34e-03 | 10 | 164 | 2 | C1631597 | |
| Disease | Hereditary hearing loss and deafness | 1.37e-03 | 146 | 164 | 5 | cv:C0236038 | |
| Disease | cholelithiasis | 1.49e-03 | 88 | 164 | 4 | EFO_0004799 | |
| Disease | pregnenetriol sulfate measurement | 1.63e-03 | 11 | 164 | 2 | EFO_0800586 | |
| Disease | plasma N-desmethylclozapine measurement | 1.63e-03 | 11 | 164 | 2 | EFO_0600039 | |
| Disease | hearing impairment | 2.21e-03 | 98 | 164 | 4 | C1384666 | |
| Disease | circadian rhythm | 2.22e-03 | 163 | 164 | 5 | EFO_0004354 | |
| Disease | IGFBP-1 measurement | 2.30e-03 | 13 | 164 | 2 | EFO_0005118 | |
| Disease | DEAFNESS, AUTOSOMAL RECESSIVE (disorder) | 2.30e-03 | 13 | 164 | 2 | C1846647 | |
| Disease | pregnenetriol disulfate measurement | 2.30e-03 | 13 | 164 | 2 | EFO_0800587 | |
| Disease | Romano-Ward Syndrome | 3.50e-03 | 16 | 164 | 2 | C0035828 | |
| Disease | idiopathic scoliosis (implicated_via_orthology) | 3.50e-03 | 16 | 164 | 2 | DOID:0060250 (implicated_via_orthology) | |
| Disease | chronotype measurement | DOCK3 RGSL1 ANK2 SEC11C KCNT2 PAFAH1B1 PKHD1 PLCL1 CFAP61 MDGA1 MTRF1L ADGRA3 | 3.94e-03 | 882 | 164 | 12 | EFO_0008328 |
| Disease | Dystonia, Limb | 3.95e-03 | 17 | 164 | 2 | C0751093 | |
| Disease | Dystonia, Diurnal | 3.95e-03 | 17 | 164 | 2 | C0393610 | |
| Disease | X-21441 measurement | 3.95e-03 | 17 | 164 | 2 | EFO_0800814 | |
| Disease | bacteriemia | 3.95e-03 | 17 | 164 | 2 | EFO_0003033 | |
| Disease | metabolite measurement | 4.24e-03 | 560 | 164 | 9 | EFO_0004725 | |
| Disease | Dystonia, Paroxysmal | 4.43e-03 | 18 | 164 | 2 | C0393588 | |
| Disease | parahippocampal gyrus volume measurement | 4.43e-03 | 18 | 164 | 2 | EFO_0010318 | |
| Disease | Post-Traumatic Osteoporosis | 4.79e-03 | 61 | 164 | 3 | C0751406 | |
| Disease | Osteoporosis, Senile | 4.79e-03 | 61 | 164 | 3 | C0029459 | |
| Disease | Osteoporosis, Age-Related | 4.79e-03 | 61 | 164 | 3 | C0001787 | |
| Disease | Osteoporosis | 5.24e-03 | 63 | 164 | 3 | C0029456 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| HGIVVFSLGSMVSEI | 301 | P35503 | |
| MEGESSRFEIHTPVS | 1 | Q15361 | |
| VTAMIGHTNVVVPRS | 251 | Q9H2P0 | |
| FPTIDHVVEAGFMTR | 151 | Q8NFU1 | |
| HVNALTVMRTAIAPG | 1056 | P48751 | |
| GSPRLFTSVMAVHRA | 116 | Q8N3I7 | |
| TVIPESTIMRTLHSG | 76 | Q99996 | |
| MSVLTSPRGKVEVVH | 1 | Q8NHU2 | |
| VTQIVMTDAGRPHSE | 761 | Q9BZ76 | |
| FLMNEVVHTSPTIGS | 36 | Q96KC2 | |
| VTHMFSLPVNGSSVV | 1011 | Q8IZF6 | |
| FDKTGTITHGVPRVM | 1026 | P35670 | |
| MTPSHRQVVFEGDSL | 246 | Q8IWK6 | |
| IVMDSGDGVTHTVPI | 151 | P60709 | |
| IVMDSGDGVTHTVPI | 151 | P63261 | |
| VPQMSSTGTVHITVI | 3591 | Q6V0I7 | |
| LVFEVTRAHVTPMDQ | 351 | Q8NCL9 | |
| DTIVGMLHNRSETPT | 201 | Q9H211 | |
| AAVVLHSPLTSGMRV | 206 | Q96GS6 | |
| GSEMTTVPLLHAAIR | 276 | Q00796 | |
| RSHSATAVDFLPVMV | 11 | Q9BYV7 | |
| RVTMLTAPLGFSVHL | 421 | Q9H816 | |
| FHVDMDSGLVTTQRP | 2556 | Q9H251 | |
| TPIMYAARDGHTQVV | 151 | Q8WWH4 | |
| MSTTFPGLVHDAEIR | 1 | Q7Z6R9 | |
| EPVFHVMGFSVTGRV | 321 | P69849 | |
| PLSRETHIFMQVADT | 431 | Q9Y5G6 | |
| STEVHMVRPGYSHRV | 131 | Q9H714 | |
| VVRTMSPHGESADSI | 1056 | O95153 | |
| VLVTSVPHAMTGSDV | 41 | O75916 | |
| DYRTRVSGVTPQHMV | 51 | Q96AZ6 | |
| VTRVIFHPVFSVMVS | 111 | P43034 | |
| LMPVVAGAVFTLTAH | 1331 | Q92621 | |
| RFPGVMENLTISAAH | 196 | Q96PH1 | |
| EPGSQMVEASLSVRH | 91 | Q9Y5K2 | |
| ATGSIPITVRHIESM | 756 | P49736 | |
| SPDVTNIRGETALHM | 456 | Q01484 | |
| EPMLTVHQTVSDVRG | 131 | Q8NFP4 | |
| RTDMFAIHPTSGVIV | 191 | Q14517 | |
| TVQVHDMGTPRLFAE | 1846 | Q14517 | |
| HTIFVRAVDGGMPTL | 2356 | Q14517 | |
| IVMDSGDGVTHTVPI | 851 | A5A3E0 | |
| EPVFHVMGFSVTGRV | 321 | Q5JPE7 | |
| LSGVVPTMHFTIAEG | 276 | Q96A54 | |
| SAVTVGPHKEFAVTM | 141 | O60496 | |
| HPVVITSFEIAMRDR | 326 | Q9NRZ9 | |
| DIPGHVFTRGMIIAV | 321 | Q13478 | |
| SVQHATVIPETMAGT | 731 | Q9H2X6 | |
| ASGHSVPVVTVVRAM | 196 | Q9BUP3 | |
| GHVMITVASPAETES | 581 | Q14703 | |
| MGIPSVRREVHSYLT | 146 | Q9UQ53 | |
| TGVDHMASPLVQTSR | 641 | A5PLN7 | |
| THVTEMQDSFVRPEG | 571 | Q6ZRS4 | |
| DVTAHAGTLPSRMTV | 331 | O43824 | |
| MTHLAAAPGTQVSRE | 2621 | Q9UKN7 | |
| PIIRVMTFVGHASGK | 501 | Q8IYD8 | |
| IMSLTGHTSPVESVR | 56 | Q9BVA0 | |
| FVPGERSVIIMNHRT | 111 | Q6UWP7 | |
| IATPGRLVHVAVEMS | 221 | Q8TDD1 | |
| VVDVREGPAFHPSTM | 376 | Q86SJ6 | |
| HATVPEMSNVGTSVI | 156 | Q86UP0 | |
| HPQVGESVSVVTVMR | 256 | Q12766 | |
| SEMFAIHPTSGVVTV | 191 | Q9NYQ8 | |
| THFVALMVTEPGLQA | 321 | Q96B70 | |
| IHVFGIVESGVLVSM | 106 | Q8NH63 | |
| LIFFVPVIGVSMVHR | 251 | Q8NGJ5 | |
| EPVFHVMGFSVTGRV | 321 | Q15155 | |
| ITGHITGMASAFRTV | 301 | Q96A46 | |
| EHASVMLDVPIRLTG | 721 | Q9UJF2 | |
| TDVSQDPRHMVLVRG | 211 | Q71SY5 | |
| TLPGRHTVEMLVISF | 171 | Q86XA0 | |
| APFLHVGAVAAVTML | 161 | Q8WTR4 | |
| VIGMGTTPEVHSIFL | 276 | P00451 | |
| PVHSIIASMGTVAID | 586 | Q6UVM3 | |
| MDVVSVHFQPLDRVS | 361 | Q9HCN3 | |
| SAHVTVVILFFGPLM | 241 | Q8NGB8 | |
| TFPRVIMQEVEHALS | 241 | Q6UWI2 | |
| RMPFLVETLHASSVE | 5051 | Q96RW7 | |
| RRLVPFTEHMISVSA | 576 | Q9UMZ3 | |
| IRGHPVTMRTITYSI | 326 | Q9NVE7 | |
| TPGVAMVLLHTTISF | 111 | Q5VTY9 | |
| ITMGSVRPSVEQFHK | 996 | Q9UHC9 | |
| IVMDSGDGVTHTVPI | 851 | Q6S8J3 | |
| ILVFRSGPHDQIMSS | 286 | Q9Y6A1 | |
| SIVTDLVSQMDPHGR | 446 | O60313 | |
| FITHGFTMTTEVPLR | 376 | Q01970 | |
| TTMILDHVFPDTGVS | 101 | O14531 | |
| ESINHVVVFMLGTIP | 31 | Q53FT3 | |
| GIPVLMHDNTVDRTT | 106 | Q9NZC3 | |
| ISHATLERIGAVPVM | 406 | Q5DX21 | |
| FVRGTLGSMPSTVHI | 811 | Q8IZD9 | |
| RFVPAEMGTHTVSVK | 2201 | P21333 | |
| FGDIVPLGVTHMTSR | 366 | P10635 | |
| PLGVTHMTSRDIEVQ | 371 | P10635 | |
| HMTSRDIEVQGFRIP | 376 | P10635 | |
| VTVTVCRSFIPDQHM | 416 | Q7Z3C6 | |
| VDATAVTDVPFQRMH | 36 | A2RUQ5 | |
| AATVLPMVRSEHVTV | 401 | Q8N1P7 | |
| VVEGNHMVYRISAPT | 346 | Q99418 | |
| LTAAHVVEGNREPTM | 471 | P09871 | |
| VNTLREVEPTSHMGV | 361 | Q96GR2 | |
| VSTPEFIHAAMRPDV | 126 | Q15723 | |
| FIHAAMRPDVITETV | 131 | Q15723 | |
| DVMVNTDPVHGLLTR | 411 | Q5T7N3 | |
| VLAGDHMQVTPRLFS | 691 | Q9BYK8 | |
| PMVHSTFLASLRAEG | 211 | Q5T4B2 | |
| IHERFGIVEGLMTTV | 236 | O14556 | |
| LAEHMPVLVSGIIFS | 471 | O75155 | |
| SGHVTRLGLSMVEFP | 476 | Q8IX18 | |
| GVSVHFRHVVPSIME | 406 | Q9Y267 | |
| HVSSMRPNIFLGVSE | 651 | Q92736 | |
| AVGMSTVPEVIVARH | 216 | P00491 | |
| GIRVIMVTGDHPITA | 621 | P20648 | |
| EALRTHPEMVFARTS | 691 | P20648 | |
| TTTDNIMLRVFPDGH | 151 | P28476 | |
| FPDGHVLYSMRITVT | 161 | P28476 | |
| SHSTGEVVVTMEPEV | 1261 | Q9HC10 | |
| HVTMVFPDAGTFSIR | 1851 | P98161 | |
| ATTVEMATGHIVPEG | 291 | P26022 | |
| MAEFIGQTGTVHRIT | 286 | Q96AX9 | |
| VFMHDNSPGRIVSIK | 1081 | P42345 | |
| RDHIIEVVGSSMPLI | 381 | P17600 | |
| LDRSVFHGAIMSVFP | 956 | A5PLK6 | |
| VLTTFHVPLVIMTFG | 126 | Q99523 | |
| MEPRRITSAASVLFH | 571 | A6NNA2 | |
| LYVVEVRHGPSSVEM | 726 | Q8IYR2 | |
| IVVVLSGSMEPAFHR | 61 | Q9BY50 | |
| ATMSVHLPFAVVGST | 226 | Q9NVA2 | |
| HQMVPGTFAVISILV | 121 | Q7LBE3 | |
| AIVHSTSDPIMTARG | 1786 | O14513 | |
| QGRVHTSTMTVAILP | 211 | Q9UGC7 | |
| GVTVPSTREVMSLHE | 1901 | P58107 | |
| FPTVHAVILLEGTMN | 241 | O75448 | |
| GMIVAEVVSARIHPE | 406 | Q9Y4R8 | |
| IVMDSGDGVTHTVPI | 851 | P0CG38 | |
| FHRMSIGLANTPEVS | 2571 | P08F94 | |
| ETVIMPVFGIATPFH | 536 | Q9Y5B9 | |
| VRTRGTLEEMPTVQH | 26 | Q9BV47 | |
| SVVDMHTGGEPLRIV | 21 | Q96EM0 | |
| VSTAGRMHIFKPVSV | 161 | Q8WYL5 | |
| PIHVFGTETHMTAIV | 401 | P53396 | |
| TGITMVIFSHHVPTV | 161 | Q01718 | |
| PVGYSRHMVVTVTRF | 211 | Q99788 | |
| DIVPLGVTHMTSRDI | 386 | A0A087X1C5 | |
| VPLRSFVGDIMEHVT | 826 | Q15111 | |
| VTMTIGVGTRHVQEF | 181 | Q8NC42 | |
| MFATVAGISQRAPVH | 231 | Q8WUH2 | |
| VEVIFHVSTRMPSDS | 1876 | Q6GYQ0 | |
| GVPDLVHVMRTLASE | 326 | P35813 | |
| PHFIRIQDAMEVTST | 626 | Q9Y2P5 | |
| HAPGSVRVQVSMTTA | 511 | Q9UPX0 | |
| RVVVETVHPGMLADA | 556 | Q76KD6 | |
| TVIFPSSHSFILIMG | 271 | Q9NYW1 | |
| SSGHVTFTMDPIRDL | 611 | O94759 | |
| HPTVLVQRGHSSMFV | 516 | Q6ZQQ2 | |
| PHAMVRVSVNGAVVL | 986 | O15067 | |
| FMSTHRIVTEGRVVT | 111 | Q5TEJ8 | |
| ASVFGTMPLKVVEHR | 681 | Q93063 | |
| MPVFHTRTIESILEP | 1 | P18206 | |
| SPRHEVTEMGQEVTL | 26 | P01733 | |
| HGIVVFSLGSMVSEI | 301 | P35504 | |
| MEPTVADVHLVPRTT | 1 | Q7Z410 | |
| VAMHTVGFAETVRDL | 231 | P55017 | |
| LFSHDAVVREMPTGV | 366 | Q04864 | |
| MTRTVTLGGDVFDPH | 646 | O95347 | |
| TFTVHMPEIALVRFL | 796 | Q4KWH8 | |
| MPAKTFAGVRVHVVD | 1171 | Q9P2E3 | |
| SPRHEVTEMGQEVTL | 26 | A0A0B4J2E0 | |
| MRTVGIHPTCSEEVV | 491 | Q9NNW7 | |
| PEVHMALDVVLVRGS | 3866 | Q7Z7G8 | |
| VIMTRLTESGHPSSD | 251 | Q9UL58 | |
| SGRHMVEISTPVLIS | 316 | Q8TEC5 | |
| ARVTQTPRHKVTEMG | 21 | A0A1B0GX78 | |
| TRTPIVTLSGHMEAV | 246 | Q9GZL7 | |
| GVISMPVAARATHRV | 1131 | P48553 | |
| ALFTETPHDMTARTG | 41 | Q96N03 | |
| EPVISAMTTGAATHV | 176 | Q8TE54 | |
| FTMETGPRASEALHT | 56 | O95932 | |
| SDTIEMVRVAGHPNV | 246 | Q5W0B7 | |
| PSVRAAFIHVIGDFM | 166 | Q9BRI3 | |
| HGIVVFSLGSMVSEI | 301 | P22310 | |
| PVHQSVTMGETVSFL | 216 | Q8TEU8 | |
| ETTRIMRVSHTFPVV | 41 | Q5VV43 |